Q4 2025 Viemed Healthcare Inc Earnings Call Transcript
Key Points
- Viemed Healthcare Inc (VMD) achieved record revenue and adjusted EBITDA in 2025, indicating strong financial performance.
- The company successfully diversified its business, with significant growth in sleep and resupply services, and expansion into maternal health.
- Viemed's proprietary Engage patient platform has enhanced compliance and operational efficiency, supporting better patient management.
- The Lehan acquisition has been accretive, contributing positively to net income and expanding Viemed's footprint in maternal health.
- Viemed maintains a strong balance sheet with effectively no net debt, providing financial flexibility for future growth and shareholder returns.
- There was a moderation in ventilator patient growth due to changes in national coverage determination, impacting short-term growth.
- Some patients who previously qualified for services under old criteria may not qualify under new standards, affecting patient volumes.
- The company faces challenges in maintaining gross margins as it diversifies into lower-margin services like sleep and maternal health.
- Viemed's growth in complex respiratory services is hindered by the transition to new documentation and process requirements.
- The company anticipates uneven quarterly growth in 2026, with potential flat or slightly down performance in the first quarter.
Greetings, and welcome to the VieMed Healthcare fourth quarter year-end quarterly earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Trae Fitzgerald, CFO. Thank you. You may begin.
Thank you, and good morning, everyone. Please note that our remarks on this conference call may include forward-looking statements under the U.S. federal securities laws or forward-looking information under applicable Canadian securities legislation, which we collectively refer to as forward-looking statements.
Such statements reflect the company's current views and intentions with respect to future results or events and are subject to certain risks and uncertainties, which could cause actual results or events to vary from those indicated in forward-looking statements. Examples of such risks and uncertainties are discussed in our disclosure documents filed with the SEC or the security regulatory authorities in certain
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
